Crossmark Global Holdings’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
7,755
+174
| +2% | +$5.75K | ﹤0.01% | 1170 |
|
|
2025
Q1 | $305K | Sell |
7,581
-46
| -0.6% | -$1.85K | 0.01% | 1079 |
|
|
2024
Q4 | $359K | Sell |
7,627
-13
| -0.2% | -$612 | 0.01% | 974 |
|
|
2024
Q3 | $403K | Buy |
7,640
+1,072
| +16% | +$56.5K | 0.01% | 956 |
|
|
2024
Q2 | $356K | Sell |
6,568
-8
| -0.1% | -$434 | 0.01% | 979 |
|
|
2024
Q1 | $461K | Sell |
6,576
-890
| -12% | -$62.4K | 0.01% | 907 |
|
|
2023
Q4 | $623K | Sell |
7,466
-603
| -7% | -$50.3K | 0.01% | 756 |
|
|
2023
Q3 | $282K | Buy |
8,069
+19
| +0.2% | +$664 | 0.01% | 1044 |
|
|
2023
Q2 | $268K | Sell |
8,050
-39
| -0.5% | -$1.3K | 0.01% | 1120 |
|
|
2023
Q1 | $284K | Buy |
8,089
+19
| +0.2% | +$667 | 0.01% | 1067 |
|
|
2022
Q4 | $370K | Sell |
8,070
-120
| -1% | -$5.5K | 0.01% | 931 |
|
|
2022
Q3 | $397K | Buy |
8,190
+490
| +6% | +$23.8K | 0.01% | 867 |
|
|
2022
Q2 | $302K | Sell |
7,700
-170
| -2% | -$6.67K | 0.01% | 1022 |
|
|
2022
Q1 | $290K | Buy |
7,870
+20
| +0.3% | +$737 | 0.01% | 1148 |
|
|
2021
Q4 | $358K | Sell |
7,850
-8,200
| -51% | -$374K | 0.01% | 1066 |
|
|
2021
Q3 | $574K | Sell |
16,050
-30
| -0.2% | -$1.07K | 0.01% | 852 |
|
|
2021
Q2 | $318K | Buy |
16,080
+130
| +0.8% | +$2.57K | 0.01% | 1148 |
|
|
2021
Q1 | $371K | Buy |
15,950
+610
| +4% | +$14.2K | 0.01% | 1063 |
|
|
2020
Q4 | $319K | Buy |
+15,340
| New | +$319K | 0.01% | 1058 |
|
|
2017
Q4 | – | Sell |
-21,460
| Closed | -$311K | – | 1654 |
|
|
2017
Q3 | $311K | Buy |
+21,460
| New | +$311K | 0.01% | 1291 |
|
|
2016
Q3 | $311K | Buy |
+21,460
| New | +$311K | 0.01% | 1291 |
|